Investor Stock List
Ranked #4,076 of 8,699 institutional investors

GSK plc

London, X0

$422M
US stock portfolio at live prices · today −$6.1M (−1.44%)
Market closed. Prices as of Nov 20, 7:11 AM ET
Value at quarter end (Q3 2026)
$497M
Change from Q2 2026
−$105.2M (−17.47%)
Positions
12 · 0 new, 0 sold out
Filed
Nov 5, 2026

Not counted in the ranking: none$144M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
VIR 18.0%BNTX 12.9%WVE 11.8%IDYA 8.27%LYEL 4.87%
StockSharesValue, live% of portfoliovs Q2 2026
VIR Vir Biotechnology, Inc.8,550,954$75.8M18.0%Unchanged
BNTX BioNTech SE668,526$54.4M12.9%Reduced −25%
WVE Wave Life Sciences, Inc.18,245,691$49.6M11.8%Unchanged
IDYA IDEAYA Biosciences, Inc.1,333,333$34.9M8.27%Unchanged
LYEL Lyell Immunopharma, Inc.1,512,659$20.5M4.87%Unchanged
CYTK Cytokinetics, Incorporated340,434$17.5M4.15%Unchanged
SPRO Spero Therapeutics, Inc.9,190,606$7.6M1.80%Unchanged
FULC Fulcrum Therapeutics, Inc.1,785,714$6.6M1.57%Unchanged
BCYC Bicycle Therapeutics plc1,529,561$4.7M1.11%Unchanged
NKTX Nkarta, Inc.3,150,732$3.5M0.84%Unchanged
RGNX REGENXBIO Inc.271,456$1.9M0.46%Unchanged
CVRX CVRx, Inc.1,007,583$537K0.13%Unchanged